CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Evercore ISI Sticks to Its Hold Rating for T Rowe Price (TROW)
Evercore ISI analyst Glenn Schorr maintained a Hold rating on T Rowe Price (TROW – Research Report) yesterday and set a price target of ...
Evercore ISI Pounds the Table on Nvidia (NVDA) Stock Ahead of Earnings
Wall Street investment bank Evercore ISI (EVR) is pounding the table on Nvidia (NVDA) stock ahead of the chipmaker’s upcoming ...
David Kamo Joins Evercore as Senior Managing Director in Investment Banking
Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business, based in New York.